遞迴製藥公司
US ˙ NasdaqGS ˙ US75629V1044

SecurityRXRX / Recursion Pharmaceuticals, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership588,312 shares
Latest Disclosed Value $ 2,976,858
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 38.36% increase in ownership of RXRX / Recursion Pharmaceuticals, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 588,312 shares of Recursion Pharmaceuticals, Inc. (US:RXRX) valued at $2,976,859 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 425,209 shares of Recursion Pharmaceuticals, Inc.. This represents a change in shares of 38.36% during the quarter. The current value of the position is $1,950,254 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Recursion Pharmaceuticals EC US75629V1044 588,312 163,103 38.36 2,977 32.33 0.0669
2025-05-28 2025-03-31 NP Recursion Pharmaceuticals EC US75629V1044 425,209 5,668 1.35 2,249 -20.70 0.0540
2025-02-25 2024-12-31 NP Recursion Pharmaceuticals EC US75629V1044 419,541 -48,417 -10.35 2,836 -8.01 0.0619
2024-11-26 2024-09-30 NP Recursion Pharmaceuticals EC US75629V1044 467,958 202,474 76.27 3,084 54.85 0.0583
2024-08-26 2024-06-30 NP Recursion Pharmaceuticals EC US75629V1044 265,484 21,660 8.88 1,991 -18.07 0.0406
2024-05-28 2024-03-31 NP Recursion Pharmaceuticals EC US75629V1044 243,824 -4,676 -1.88 2,431 -0.82 0.0507
2024-02-26 2023-12-31 NP Recursion Pharmaceuticals EC US75629V1044 248,500 16,358 7.05 2,450 38.03 0.0523
2023-11-28 2023-09-30 NP Recursion Pharmaceuticals EC US75629V1044 232,142 -6,242 -2.62 1,776 -0.28 0.0463
2023-08-25 2023-06-30 NP Recursion Pharmaceuticals EC US75629V1044 238,384 22,774 10.56 1,781 23.78 0.0422
2023-05-26 2023-03-31 NP Recursion Pharmaceuticals EC US75629V1044 215,610 0 0.00 1,438 -13.48 0.0383
2023-02-24 2022-12-31 NP Recursion Pharmaceuticals EC US75629V1044 215,610 -11,329 -4.99 1,662 -31.15 0.0457
2022-11-25 2022-09-30 NP Recursion Pharmaceuticals EC US75629V1044 226,939 18,037 8.63 2,415 42.00 0.0692
2022-08-25 2022-06-30 NP Recursion Pharmaceuticals EC US75629V1044 208,902 28,514 15.81 1,700 31.68 0.0470
2022-05-26 2022-03-31 NP Recursion Pharmaceuticals EC US75629V1044 180,388 3,759 2.13 1,292 -57.32 0.0301
2022-02-25 2021-12-31 NP Recursion Pharmaceuticals EC US75629V1044 176,629 133,298 307.63 3,026 203.41 0.0656
2021-11-24 2021-09-30 NP Recursion Pharmaceuticals EC US75629V1044 43,331 12,032 38.44 997 -12.70 0.0220
2021-08-26 2021-06-30 NP Recursion Pharmaceuticals EC US75629V1044 31,299 31,299 1,142 0.0245
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.